ArticleAllergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology2024

fSCIG 10% in pediatric primary immunodeficiency diseases: a European post-authorization safety study.

Peter Čižnár et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.